Intravascular HBO(2) saturations, perfusion and hypoxia in spontaneous and transplanted tumor models.
Clinical trials utilizing strategies to manipulate tumor oxygenation, blood flow and angiogenesis are under way, although limited quantitative information exists regarding basic tumor pathophysiology. The current study utilized murine KHT fibrosarcomas, spontaneous mammary carcinomas and first-generation spontaneous transplants to examine heterogeneity in vascular structure and function, to relate these changes to the distribution of tumor hypoxia and to determine whether fundamental relationships among the different pathophysiological parameters exist. Three methods were included: (i) immunohistochemical staining of anatomical and perfused blood vessels, (ii) cryospectrophotometric measurement of intravascular oxyhemoglobin saturations and (iii) fluorescent detection of the EF5 hypoxic marker. While a distinct pattern of decreasing oxygenation with increasing distance from the tumor surface was observed for KHT tumors, striking intertumor variability was found in both spontaneous and first-generation transplants, with a reduced dependence on tumor volume. EF5 hypoxic marker uptake was also much more heterogeneous among individual spontaneous and first-generation tumors compared to KHT. Although mammary carcinomas demonstrated fewer anatomical blood vessels than fibrosarcomas, the proportion of perfused vessels was substantially reduced in KHT tumors, especially at larger tumor volumes. Vascular morphology, tissue histological appearance and pathophysiological parameters differed substantially between KHT tumors and both spontaneous and first-generation tumors. Such differences in vascular structure and function are also likely to correlate with altered response to therapies targeted to the vascular system. Finally, spontaneous differentiation status, tumor morphology, vascular configuration and function were well preserved in first-generation transplanted tumors, suggesting a close relationship between vascular development and function in early-generation transplants and spontaneous tumor models.
Fenton
B M
BM
Department of Radiation Oncology, University of Rochester School of Medicine, Rochester, NY, USA. bruce_fenton@urmc.rochester.edu
Lord
E M
EM
Paoni
S F
SF
D000818:Animals; D001881:Borates / Q000097:blood*; D017610:Calcium Compounds / Q000097:blood*; D004195:Disease Models, Animal; D017341:Etanidazole / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology; D000860:Hypoxia; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000097:blood* / Q000378:metabolism / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D010100:Oxygen / Q000378:metabolism*; D010477:Perfusion; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology; D005466:Fluorocarbons
D001881:Borates; D017610:Calcium Compounds; D017341:Etanidazole; D006845:Hydrocarbons, Fluorinated; D010100:Oxygen; D011838:Radiation-Sensitizing Agents; C096011:2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide; D005466:Fluorocarbons; C031316:calcium borate